Amo Pharma
Develops investigational treatments for serious diseases, particularly rare genetic disorders, for patients with unmet medical needs
Highlights
- New on EvolcAdded 2026-11-08
About Amo Pharma
AMO Pharma is a biopharmaceutical company developing treatments for serious and debilitating diseases, particularly rare and orphan diseases. Its portfolio includes clinical-stage investigational drugs targeting neuromuscular or central nervous system symptoms of rare diseases.
The company identifies and advances therapies through clinical development, including for new indications. Its approach involves patients, researchers and physicians in drug development.
AMO Pharma Limited was founded in 2015 and is headquartered in Leeds. Senior leadership is based in the U.S. and U.K.
Product: Clinical-stage investigational drug therapies for serious diseases, including rare genetic disorders.
Jobs at Amo Pharma
Leadership
- Michael Snape · Chief Executive Officer & Chief Scientific OfficerSource: company website
- Martyn Williams · Chief Financial OfficerSource: company website
More biotech & pharma companies
Amphista Therapeutics
Develops Targeted Glue protein-degrader medicines for cancer, with a lead acute myeloid leukemia candidate in Phase 1New on EvolcAnanda Pharma
Develops cannabinoid-based medicines for inflammatory pain conditions and heart failureNew on EvolcAndrolabs
Men's health medicines, including testosterone replacement and erectile dysfunction therapies, for patients and healthcare professionalsNew on EvolcAntigenika
Developing an oral, broad-spectrum snakebite treatment for people in regions with limited access to hospital antivenomYoung companyNew on EvolcAntiverse
AI-guided antibody discovery and laboratory validation for pharmaceutical and biotech partners targeting GPCRsNew on EvolcApconix
Nonclinical drug safety consultancy and ion channel screening lab for pharma and biotech drug developersNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Universal AnalyticsMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinitialization/configuration expression
- Integration code on pageinitialization/configuration expression
- Integration code on pageinitialization/configuration expression
Frontend frameworks
- BootstrapHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- nginxHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.